Postbiotica Competitors

Growth of our customers'​ business is at the heart of what we do. The strength of Epicor business solutions lies in a simplified approach to technology, inspired by our customers and how they work. More than 45 years of experience with our customers’ unique processes and operational requirements is built into every solution. We provide flexible, industry-specific software that is designed around the precise needs of our manufacturing, distribution, retail, and service industry customers. With a deep understanding of your industry, Epicor solutions promote growth while managing complexity. The result is powerful solutions that do exactly what you need—free your resources so you can profitably grow your business.

Lallemand is a privately owned company, founded at the end of the 19th century that researches, develops, produces and markets yeasts, bacteria and related products with the aim of reproducing, managing and optimizing natural fermentation processes in agri-food industries. Administrative offices for the parent company are in Montreal, Canada. Today, Lallemand employs more than 4300 people working across more than 45 countries, on 5 continents. We are more than a global leader in yeast and bacterial cultures. We are both an international company and a family business that relies on the expertise of its employees to thrive. Working at Lallemand means enjoying the stature of a century-old company that is constantly growing, and having career opportunities around the globe at your fingertips. Do you value passion, collaboration, innovation, and autonomy? If so, we want to get to know you! At Lallemand, you will find a team that is dedicated to offering its best to each client. We have a direct impact on the daily lives of millions, so we must always remain one step ahead – this means constantly staying attentive to our clients and anticipating their needs. If your personal aspirations align with ours, take a look at our job postings. You might just find your next professional challenge!

Eureka Therapeutics is a privately held biotechnology company located in the San Francisco Bay Area, focused on breakthrough immunotherapies for the treatment of cancer. Utilizing our antibody drug discovery and engineering technologies, we are advancing safe and effective therapies for targeting previously inaccessible cancer antigens. We have built an early stage pipeline of innovative drugs, with the most advanced candidates at pre-clinical stage. Eureka Therapeutics is a leader in the discovery of novel antibody immunotherapies. We utilize a paradigm-changing technology platform to develop fully-human antibodies against intracellular cancer antigens. In collaboration with Memorial Sloan-Kettering Cancer Center, we were the first-to-demonstrate in vivo efficacy of a human IgG1 antibody against an intracellular cancer antigen. Our most advanced program is at preclinical stage and being developed in partnership with Novartis.